ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.123,86
0,28%
S&P 500
5.473,23
0,00%
Dow Jones
38.778,10
0,00%
Euro vs US Dollar
1,07264
-0,13%
Bitcoin
64.917,47
-2,36%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. MDxHealth SA (MDXH)

  7. MDxHealth SA (MDXH) News

MDXH

MDxHealth (MDXH)

MDxHealth SA
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MDXH
DatumZeitQuelleÜberschriftSymbolFirma
05/06/202423h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
15/05/202422h00GlobeNewswire Inc.Mdxhealth to Present at Upcoming Investor ConferencesNASDAQ:MDXHMDxHealth SA
01/05/202413h45GlobeNewswire Inc.MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMedNASDAQ:MDXHMDxHealth SA
12/03/202421h00GlobeNewswire Inc.Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer OfferingNASDAQ:MDXHMDxHealth SA
06/03/202422h00GlobeNewswire Inc.Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:MDXHMDxHealth SA
21/02/202423h00GlobeNewswire Inc.MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6NASDAQ:MDXHMDxHealth SA
16/02/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
08/01/202422h39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
15/11/202322h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
08/11/202322h23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
08/11/202322h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
06/11/202314h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
23/10/202323h09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
10/08/202322h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
05/07/202323h27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
06/06/202323h30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
26/05/202322h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
15/05/202322h26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
26/04/202322h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
14/04/202322h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
09/03/202312h07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
28/02/202322h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDXHMDxHealth SA
28/02/202322h07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MDXHMDxHealth SA
23/02/202312h03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
14/02/202312h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MDXHMDxHealth SA
09/02/202322h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
06/02/202323h26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MDXHMDxHealth SA
01/02/202322h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MDXHMDxHealth SA
20/01/202312h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
09/01/202322h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
 Showing the most relevant articles for your search:NASDAQ:MDXH

Kürzlich von Ihnen besucht

LSE
TRGB
Ivz Ust Gbh
USOTC
RTDTS
RSE Collection (GM)
BIT
UC0HLE
Unicredit Bank
KUCN
ELIXETH
Elixir
ASX
PGC
Paragon Care
LSE
AO17
Citi Fun 24
EU
I088T
I088T
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten